+1 (704) 266-3234

Global Sleep Disorder Therapeutics Market Size, Status And Forecast 2020-2026

Published on: Jul 2020 | From USD $3900 | Published By: QY RESEARCH | Number Of Pages: 96

Sleep Disorder Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sleep Disorder Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Sanofi
Sunovion Pharmaceuticals
Takeda Pharmaceutical
Somaxon Pharmaceuticals
Vanda Pharmaceuticals
Eli Lilly
GSK
Neurim Pharmaceuticals

Market segment by Type, the product can be split into
Insomnia
Excessive Sleep
Disturbed Sleep
Market segment by Application, split into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Sleep Disorder Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Sleep Disorder Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Insomnia
1.4.3 Excessive Sleep
1.4.4 Disturbed Sleep
1.5 Market by Application
1.5.1 Global Sleep Disorder Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Sleep Disorder Therapeutics Market Perspective (2015-2026)
2.2 Global Sleep Disorder Therapeutics Growth Trends by Regions
2.2.1 Sleep Disorder Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Sleep Disorder Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Sleep Disorder Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Sleep Disorder Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Sleep Disorder Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Sleep Disorder Therapeutics Players by Market Size
3.1.1 Global Top Sleep Disorder Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Sleep Disorder Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Sleep Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Sleep Disorder Therapeutics Market Concentration Ratio
3.2.1 Global Sleep Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Sleep Disorder Therapeutics Revenue in 2019
3.3 Sleep Disorder Therapeutics Key Players Head office and Area Served
3.4 Key Players Sleep Disorder Therapeutics Product Solution and Service
3.5 Date of Enter into Sleep Disorder Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Sleep Disorder Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Sleep Disorder Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Sleep Disorder Therapeutics Market Size by Application (2015-2020)
5.2 Global Sleep Disorder Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Sleep Disorder Therapeutics Market Size (2015-2020)
6.2 Sleep Disorder Therapeutics Key Players in North America (2019-2020)
6.3 North America Sleep Disorder Therapeutics Market Size by Type (2015-2020)
6.4 North America Sleep Disorder Therapeutics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Sleep Disorder Therapeutics Market Size (2015-2020)
7.2 Sleep Disorder Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Sleep Disorder Therapeutics Market Size by Type (2015-2020)
7.4 Europe Sleep Disorder Therapeutics Market Size by Application (2015-2020)

8 China
8.1 China Sleep Disorder Therapeutics Market Size (2015-2020)
8.2 Sleep Disorder Therapeutics Key Players in China (2019-2020)
8.3 China Sleep Disorder Therapeutics Market Size by Type (2015-2020)
8.4 China Sleep Disorder Therapeutics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Sleep Disorder Therapeutics Market Size (2015-2020)
9.2 Sleep Disorder Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Sleep Disorder Therapeutics Market Size by Type (2015-2020)
9.4 Japan Sleep Disorder Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Sleep Disorder Therapeutics Market Size (2015-2020)
10.2 Sleep Disorder Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Sleep Disorder Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Sleep Disorder Therapeutics Market Size by Application (2015-2020)

11 India
11.1 India Sleep Disorder Therapeutics Market Size (2015-2020)
11.2 Sleep Disorder Therapeutics Key Players in India (2019-2020)
11.3 India Sleep Disorder Therapeutics Market Size by Type (2015-2020)
11.4 India Sleep Disorder Therapeutics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Sleep Disorder Therapeutics Market Size (2015-2020)
12.2 Sleep Disorder Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Sleep Disorder Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Sleep Disorder Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Sanofi
13.1.1 Sanofi Company Details
13.1.2 Sanofi Business Overview
13.1.3 Sanofi Sleep Disorder Therapeutics Introduction
13.1.4 Sanofi Revenue in Sleep Disorder Therapeutics Business (2015-2020))
13.1.5 Sanofi Recent Development
13.2 Sunovion Pharmaceuticals
13.2.1 Sunovion Pharmaceuticals Company Details
13.2.2 Sunovion Pharmaceuticals Business Overview
13.2.3 Sunovion Pharmaceuticals Sleep Disorder Therapeutics Introduction
13.2.4 Sunovion Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2015-2020)
13.2.5 Sunovion Pharmaceuticals Recent Development
13.3 Takeda Pharmaceutical
13.3.1 Takeda Pharmaceutical Company Details
13.3.2 Takeda Pharmaceutical Business Overview
13.3.3 Takeda Pharmaceutical Sleep Disorder Therapeutics Introduction
13.3.4 Takeda Pharmaceutical Revenue in Sleep Disorder Therapeutics Business (2015-2020)
13.3.5 Takeda Pharmaceutical Recent Development
13.4 Somaxon Pharmaceuticals
13.4.1 Somaxon Pharmaceuticals Company Details
13.4.2 Somaxon Pharmaceuticals Business Overview
13.4.3 Somaxon Pharmaceuticals Sleep Disorder Therapeutics Introduction
13.4.4 Somaxon Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2015-2020)
13.4.5 Somaxon Pharmaceuticals Recent Development
13.5 Vanda Pharmaceuticals
13.5.1 Vanda Pharmaceuticals Company Details
13.5.2 Vanda Pharmaceuticals Business Overview
13.5.3 Vanda Pharmaceuticals Sleep Disorder Therapeutics Introduction
13.5.4 Vanda Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2015-2020)
13.5.5 Vanda Pharmaceuticals Recent Development
13.6 Eli Lilly
13.6.1 Eli Lilly Company Details
13.6.2 Eli Lilly Business Overview
13.6.3 Eli Lilly Sleep Disorder Therapeutics Introduction
13.6.4 Eli Lilly Revenue in Sleep Disorder Therapeutics Business (2015-2020)
13.6.5 Eli Lilly Recent Development
13.7 GSK
13.7.1 GSK Company Details
13.7.2 GSK Business Overview
13.7.3 GSK Sleep Disorder Therapeutics Introduction
13.7.4 GSK Revenue in Sleep Disorder Therapeutics Business (2015-2020)
13.7.5 GSK Recent Development
13.8 Neurim Pharmaceuticals
13.8.1 Neurim Pharmaceuticals Company Details
13.8.2 Neurim Pharmaceuticals Business Overview
13.8.3 Neurim Pharmaceuticals Sleep Disorder Therapeutics Introduction
13.8.4 Neurim Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2015-2020)
13.8.5 Neurim Pharmaceuticals Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Sleep Disorder Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Sleep Disorder Therapeutics Revenue
Table 3. Ranking of Global Top Sleep Disorder Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Sleep Disorder Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Insomnia
Table 6. Key Players of Excessive Sleep
Table 7. Key Players of Disturbed Sleep
Table 8. Global Sleep Disorder Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Sleep Disorder Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Sleep Disorder Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Sleep Disorder Therapeutics Market Share by Regions (2015-2020)
Table 12. Global Sleep Disorder Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Sleep Disorder Therapeutics Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Sleep Disorder Therapeutics Market Growth Strategy
Table 18. Main Points Interviewed from Key Sleep Disorder Therapeutics Players
Table 19. Global Sleep Disorder Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 20. Global Sleep Disorder Therapeutics Market Share by Players (2015-2020)
Table 21. Global Top Sleep Disorder Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sleep Disorder Therapeutics as of 2019)
Table 22. Global Sleep Disorder Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Sleep Disorder Therapeutics Product Solution and Service
Table 25. Date of Enter into Sleep Disorder Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Sleep Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 28. Global Sleep Disorder Therapeutics Market Size Share by Type (2015-2020)
Table 29. Global Sleep Disorder Therapeutics Revenue Market Share by Type (2021-2026)
Table 30. Global Sleep Disorder Therapeutics Market Size Share by Application (2015-2020)
Table 31. Global Sleep Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 32. Global Sleep Disorder Therapeutics Market Size Share by Application (2021-2026)
Table 33. North America Key Players Sleep Disorder Therapeutics Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Sleep Disorder Therapeutics Market Share (2019-2020)
Table 35. North America Sleep Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 36. North America Sleep Disorder Therapeutics Market Share by Type (2015-2020)
Table 37. North America Sleep Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 38. North America Sleep Disorder Therapeutics Market Share by Application (2015-2020)
Table 39. Europe Key Players Sleep Disorder Therapeutics Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Sleep Disorder Therapeutics Market Share (2019-2020)
Table 41. Europe Sleep Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Sleep Disorder Therapeutics Market Share by Type (2015-2020)
Table 43. Europe Sleep Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Sleep Disorder Therapeutics Market Share by Application (2015-2020)
Table 45. China Key Players Sleep Disorder Therapeutics Revenue (2019-2020) (Million US$)
Table 46. China Key Players Sleep Disorder Therapeutics Market Share (2019-2020)
Table 47. China Sleep Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 48. China Sleep Disorder Therapeutics Market Share by Type (2015-2020)
Table 49. China Sleep Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 50. China Sleep Disorder Therapeutics Market Share by Application (2015-2020)
Table 51. Japan Key Players Sleep Disorder Therapeutics Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Sleep Disorder Therapeutics Market Share (2019-2020)
Table 53. Japan Sleep Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Sleep Disorder Therapeutics Market Share by Type (2015-2020)
Table 55. Japan Sleep Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Sleep Disorder Therapeutics Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Sleep Disorder Therapeutics Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Sleep Disorder Therapeutics Market Share (2019-2020)
Table 59. Southeast Asia Sleep Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Sleep Disorder Therapeutics Market Share by Type (2015-2020)
Table 61. Southeast Asia Sleep Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Sleep Disorder Therapeutics Market Share by Application (2015-2020)
Table 63. India Key Players Sleep Disorder Therapeutics Revenue (2019-2020) (Million US$)
Table 64. India Key Players Sleep Disorder Therapeutics Market Share (2019-2020)
Table 65. India Sleep Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 66. India Sleep Disorder Therapeutics Market Share by Type (2015-2020)
Table 67. India Sleep Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 68. India Sleep Disorder Therapeutics Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Sleep Disorder Therapeutics Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Sleep Disorder Therapeutics Market Share (2019-2020)
Table 71. Central & South America Sleep Disorder Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Sleep Disorder Therapeutics Market Share by Type (2015-2020)
Table 73. Central & South America Sleep Disorder Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Sleep Disorder Therapeutics Market Share by Application (2015-2020)
Table 75. Sanofi Company Details
Table 76. Sanofi Business Overview
Table 77. Sanofi Product
Table 78. Sanofi Revenue in Sleep Disorder Therapeutics Business (2015-2020) (Million US$)
Table 79. Sanofi Recent Development
Table 80. Sunovion Pharmaceuticals Company Details
Table 81. Sunovion Pharmaceuticals Business Overview
Table 82. Sunovion Pharmaceuticals Product
Table 83. Sunovion Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2015-2020) (Million US$)
Table 84. Sunovion Pharmaceuticals Recent Development
Table 85. Takeda Pharmaceutical Company Details
Table 86. Takeda Pharmaceutical Business Overview
Table 87. Takeda Pharmaceutical Product
Table 88. Takeda Pharmaceutical Revenue in Sleep Disorder Therapeutics Business (2015-2020) (Million US$)
Table 89. Takeda Pharmaceutical Recent Development
Table 90. Somaxon Pharmaceuticals Company Details
Table 91. Somaxon Pharmaceuticals Business Overview
Table 92. Somaxon Pharmaceuticals Product
Table 93. Somaxon Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2015-2020) (Million US$)
Table 94. Somaxon Pharmaceuticals Recent Development
Table 95. Vanda Pharmaceuticals Company Details
Table 96. Vanda Pharmaceuticals Business Overview
Table 97. Vanda Pharmaceuticals Product
Table 98. Vanda Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2015-2020) (Million US$)
Table 99. Vanda Pharmaceuticals Recent Development
Table 100. Eli Lilly Company Details
Table 101. Eli Lilly Business Overview
Table 102. Eli Lilly Product
Table 103. Eli Lilly Revenue in Sleep Disorder Therapeutics Business (2015-2020) (Million US$)
Table 104. Eli Lilly Recent Development
Table 105. GSK Company Details
Table 106. GSK Business Overview
Table 107. GSK Product
Table 108. GSK Revenue in Sleep Disorder Therapeutics Business (2015-2020) (Million US$)
Table 109. GSK Recent Development
Table 110. Neurim Pharmaceuticals Business Overview
Table 111. Neurim Pharmaceuticals Product
Table 112. Neurim Pharmaceuticals Company Details
Table 113. Neurim Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2015-2020) (Million US$)
Table 114. Neurim Pharmaceuticals Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sleep Disorder Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Insomnia Features
Figure 3. Excessive Sleep Features
Figure 4. Disturbed Sleep Features
Figure 5. Global Sleep Disorder Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Sleep Disorder Therapeutics Report Years Considered
Figure 10. Global Sleep Disorder Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Sleep Disorder Therapeutics Market Share by Regions: 2020 VS 2026
Figure 12. Global Sleep Disorder Therapeutics Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Sleep Disorder Therapeutics Market Share by Players in 2019
Figure 15. Global Top Sleep Disorder Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sleep Disorder Therapeutics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Sleep Disorder Therapeutics Revenue in 2019
Figure 17. North America Sleep Disorder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Sleep Disorder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Sleep Disorder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Sleep Disorder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Sleep Disorder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Sleep Disorder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Sleep Disorder Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $3900
USD $5850
USD $7800
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.